OrbiMed Asia Partners has led a $19 million Series B round of funding for InventisBio, a pharmaceutical developer based in Shanghai with operations in China and the US.
Existing investor Lilly Asia Ventures (LAV) also participated in the round, according to a statement. The company will use the capital to accelerate development on four drug candidates for cancer and gout,...
HESTA has acquired a A$120 million ($85 million) equity stake in Australian enterprise software and IT services provider Citadel, following its merger with medical practice software specialist Genie Solutions.
CVC Capital Partners has agreed to sell Malaysia-based snack foods producer Munchy Food Industries to Universal Robina Corporation (URC) – a branded consumer food and beverage business in the Philippines – for MYR1.93 billion ($454 million).
There is not enough capital in Asia to address the number of secondary opportunities – mirroring the situation globally – with investors claiming to have more transaction choices than ever before.
Moore Threads, a Chinese chip designer established 13 months ago by a team from Nvidia, has closed Series A at RMB2 billion ($313 million) led by Shanghai Guosheng Capital, 5Y Capital, and a BOC International fund.